Cardiovascular Implants Market Forecast to 2027 - Covid-19 Impact and Global Analysis - by Product (Coronary Stent Devices, Prosthetic Heart Valves, Cardiac Rhythm Management Devices); Application (Congestive Heart Failure, Arrhythmias, Acute Myocardial Infarction, Myocardial Ischemia, Others) and Geography
Report Code: TIPRE00003519 No. of Pages: 150 Category: Medical Device Status: Upcoming
MARKET INTRODUCTION
Cardiovascular implants are generally delicate devices that are used to implant as a substitute to a patient living with a heart disorder. These devices can be classifies as into two major categories, one is which is implanted for longer period of time and other that are used during the patient's stay in hospital after the surgery. The implants allow patients to recover faster. The implants includes pacemaker, defibrillators, stents and others.
MARKET DYNAMICS
The cardiovascular implants market is expected to grow in the rapidly in the forecast period, owing to rising prevalence, of the cardiovascular diseases, rise in the incidences of diabetes and obesity that leads to various cardiovascular conditions. The market is likely to create growth opportunities due to involvement of the new cardiovascular device therapies for atrial fibrillation (AF) and heart failure (HF).
MARKET SCOPE
The "Global Cardiovascular Implants Market Analysis to 2027" is a specialized and in-depth study of the medical device with a special focus on the global market trend analysis. The report aims to provide an overview of cardiovascular implants market with detailed market segmentation by product, application and geography. The global cardiovascular implants market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading cardiovascular implants market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global cardiovascular implants market is segmented on the basis of product and application. On the basis of the product the market is segmented as coronary stents devices, prosthetic heart valves and cardiac rhythm management devices. On the basis of application the market is classified as congestive heart failure, arrhythmias, acute myocardial infarction, myocardial ischemia and others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global cardiovascular implants market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The cardiovascular implants market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting cardiovascular implants market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the cardiovascular implants market in these regions.
MARKET PLAYERS
The reports cover key developments in the cardiovascular implants market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from cardiovascular implants market are anticipated to lucrative growth opportunities in the future with the rising demand for cardiovascular implants market in the global market. Below mentioned is the list of few companies engaged in the cardiovascular implants market.
The report also includes the profiles of key cardiovascular implants market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
Cardiovascular implants are generally delicate devices that are used to implant as a substitute to a patient living with a heart disorder. These devices can be classifies as into two major categories, one is which is implanted for longer period of time and other that are used during the patient's stay in hospital after the surgery. The implants allow patients to recover faster. The implants includes pacemaker, defibrillators, stents and others.
MARKET DYNAMICS
The cardiovascular implants market is expected to grow in the rapidly in the forecast period, owing to rising prevalence, of the cardiovascular diseases, rise in the incidences of diabetes and obesity that leads to various cardiovascular conditions. The market is likely to create growth opportunities due to involvement of the new cardiovascular device therapies for atrial fibrillation (AF) and heart failure (HF).
MARKET SCOPE
The "Global Cardiovascular Implants Market Analysis to 2027" is a specialized and in-depth study of the medical device with a special focus on the global market trend analysis. The report aims to provide an overview of cardiovascular implants market with detailed market segmentation by product, application and geography. The global cardiovascular implants market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading cardiovascular implants market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global cardiovascular implants market is segmented on the basis of product and application. On the basis of the product the market is segmented as coronary stents devices, prosthetic heart valves and cardiac rhythm management devices. On the basis of application the market is classified as congestive heart failure, arrhythmias, acute myocardial infarction, myocardial ischemia and others.
REGIONAL FRAMEWORK
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global cardiovascular implants market based on various segments. It also provides market size and forecast estimates from year 2017 to 2027 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The cardiovascular implants market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting cardiovascular implants market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the cardiovascular implants market in these regions.
MARKET PLAYERS
The reports cover key developments in the cardiovascular implants market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market payers from cardiovascular implants market are anticipated to lucrative growth opportunities in the future with the rising demand for cardiovascular implants market in the global market. Below mentioned is the list of few companies engaged in the cardiovascular implants market.
The report also includes the profiles of key cardiovascular implants market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
- Vascutek Ltd (Terumo Corporation)
- Edwards Lifesciences Corporation
- Cook
- Medtronic
- Boston Scientific Corporation
- Abbott
- Biotronik, Inc.
- Syncardia Systems, LLC
- Livanova Plc
- Integra Lifesciences
TABLE OF CONTENTS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Cardiovascular Implants Market - By Product
1.3.2 Cardiovascular Implants Market - By Application
1.3.3 Cardiovascular Implants Market - By Region
1.3.3.1 By Country
2. KEY TAKEWAYS
3. RESEARCH METHODOLOGY
4. CARDIOVASCULAR IMPLANTS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. CARDIOVASCULAR IMPLANTS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. CARDIOVASCULAR IMPLANTS MARKET - GLOBAL MARKET ANALYSIS
6.1. CARDIOVASCULAR IMPLANTS - GLOBAL MARKET OVERVIEW
6.2. CARDIOVASCULAR IMPLANTS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. CARDIOVASCULAR IMPLANTS MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. CORONARY STENT DEVICES
7.3.1. Overview
7.3.2. Coronary Stent Devices Market Forecast and Analysis
7.3.3. Bare Metal Stents Market
7.3.3.1. Overview
7.3.3.2. Bare Metal Stents Market Forecast and Analysis
7.3.4. Bioabsorbable Stents Market
7.3.4.1. Overview
7.3.4.2. Bioabsorbable Stents Market Forecast and Analysis
7.3.5. Drug Eluting Stents Market
7.3.5.1. Overview
7.3.5.2. Drug Eluting Stents Market Forecast and Analysis
7.4. PROSTHETIC HEART VALVES
7.4.1. Overview
7.4.2. Prosthetic Heart Valves Market Forecast and Analysis
7.4.3. Transcatheter Aortic Valve Implantation Market
7.4.3.1. Overview
7.4.3.2. Transcatheter Aortic Valve Implantation Market Forecast and Analysis
7.4.4. Mechanical Heart Valve Market
7.4.4.1. Overview
7.4.4.2. Mechanical Heart Valve Market Forecast and Analysis
7.4.5. Tissue Heart Valve Market
7.4.5.1. Overview
7.4.5.2. Tissue Heart Valve Market Forecast and Analysis
7.5. CARDIAC RHYTHM MANAGEMENT DEVICES
7.5.1. Overview
7.5.2. Cardiac Rhythm Management Devices Market Forecast and Analysis
7.5.3. Pacemaker Market
7.5.3.1. Overview
7.5.3.2. Pacemaker Market Forecast and Analysis
7.5.4. Cardiac Resynchronization Therapy Devices Market
7.5.4.1. Overview
7.5.4.2. Cardiac Resynchronization Therapy Devices Market Forecast and Analysis
7.5.5. Implantable Cardioverter Defibrillator Devices Market
7.5.5.1. Overview
7.5.5.2. Implantable Cardioverter Defibrillator Devices Market Forecast and Analysis
8. CARDIOVASCULAR IMPLANTS MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. CONGESTIVE HEART FAILURE
8.3.1. Overview
8.3.2. Congestive Heart Failure Market Forecast and Analysis
8.4. ARRHYTHMIAS
8.4.1. Overview
8.4.2. Arrhythmias Market Forecast and Analysis
8.5. ACUTE MYOCARDIAL INFARCTION
8.5.1. Overview
8.5.2. Acute Myocardial Infarction Market Forecast and Analysis
8.6. MYOCARDIAL ISCHEMIA
8.6.1. Overview
8.6.2. Myocardial Ischemia Market Forecast and Analysis
8.7. OTHERS
8.7.1. Overview
8.7.2. Others Market Forecast and Analysis
9. CARDIOVASCULAR IMPLANTS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Cardiovascular Implants Market Overview
9.1.2 North America Cardiovascular Implants Market Forecasts and Analysis
9.1.3 North America Cardiovascular Implants Market Forecasts and Analysis - By Product
9.1.4 North America Cardiovascular Implants Market Forecasts and Analysis - By Application
9.1.5 North America Cardiovascular Implants Market Forecasts and Analysis - By Countries
9.1.5.1 United States Cardiovascular Implants Market
9.1.5.1.1 United States Cardiovascular Implants Market by Product
9.1.5.1.2 United States Cardiovascular Implants Market by Application
9.1.5.2 Canada Cardiovascular Implants Market
9.1.5.2.1 Canada Cardiovascular Implants Market by Product
9.1.5.2.2 Canada Cardiovascular Implants Market by Application
9.1.5.3 Mexico Cardiovascular Implants Market
9.1.5.3.1 Mexico Cardiovascular Implants Market by Product
9.1.5.3.2 Mexico Cardiovascular Implants Market by Application
9.2. EUROPE
9.2.1 Europe Cardiovascular Implants Market Overview
9.2.2 Europe Cardiovascular Implants Market Forecasts and Analysis
9.2.3 Europe Cardiovascular Implants Market Forecasts and Analysis - By Product
9.2.4 Europe Cardiovascular Implants Market Forecasts and Analysis - By Application
9.2.5 Europe Cardiovascular Implants Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Cardiovascular Implants Market
9.2.5.1.1 Germany Cardiovascular Implants Market by Product
9.2.5.1.2 Germany Cardiovascular Implants Market by Application
9.2.5.2 France Cardiovascular Implants Market
9.2.5.2.1 France Cardiovascular Implants Market by Product
9.2.5.2.2 France Cardiovascular Implants Market by Application
9.2.5.3 Italy Cardiovascular Implants Market
9.2.5.3.1 Italy Cardiovascular Implants Market by Product
9.2.5.3.2 Italy Cardiovascular Implants Market by Application
9.2.5.4 Spain Cardiovascular Implants Market
9.2.5.4.1 Spain Cardiovascular Implants Market by Product
9.2.5.4.2 Spain Cardiovascular Implants Market by Application
9.2.5.5 United Kingdom Cardiovascular Implants Market
9.2.5.5.1 United Kingdom Cardiovascular Implants Market by Product
9.2.5.5.2 United Kingdom Cardiovascular Implants Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Cardiovascular Implants Market Overview
9.3.2 Asia-Pacific Cardiovascular Implants Market Forecasts and Analysis
9.3.3 Asia-Pacific Cardiovascular Implants Market Forecasts and Analysis - By Product
9.3.4 Asia-Pacific Cardiovascular Implants Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Cardiovascular Implants Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Cardiovascular Implants Market
9.3.5.1.1 Australia Cardiovascular Implants Market by Product
9.3.5.1.2 Australia Cardiovascular Implants Market by Application
9.3.5.2 China Cardiovascular Implants Market
9.3.5.2.1 China Cardiovascular Implants Market by Product
9.3.5.2.2 China Cardiovascular Implants Market by Application
9.3.5.3 India Cardiovascular Implants Market
9.3.5.3.1 India Cardiovascular Implants Market by Product
9.3.5.3.2 India Cardiovascular Implants Market by Application
9.3.5.4 Japan Cardiovascular Implants Market
9.3.5.4.1 Japan Cardiovascular Implants Market by Product
9.3.5.4.2 Japan Cardiovascular Implants Market by Application
9.3.5.5 South Korea Cardiovascular Implants Market
9.3.5.5.1 South Korea Cardiovascular Implants Market by Product
9.3.5.5.2 South Korea Cardiovascular Implants Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Cardiovascular Implants Market Overview
9.4.2 Middle East and Africa Cardiovascular Implants Market Forecasts and Analysis
9.4.3 Middle East and Africa Cardiovascular Implants Market Forecasts and Analysis - By Product
9.4.4 Middle East and Africa Cardiovascular Implants Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Cardiovascular Implants Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Cardiovascular Implants Market
9.4.5.1.1 South Africa Cardiovascular Implants Market by Product
9.4.5.1.2 South Africa Cardiovascular Implants Market by Application
9.4.5.2 Saudi Arabia Cardiovascular Implants Market
9.4.5.2.1 Saudi Arabia Cardiovascular Implants Market by Product
9.4.5.2.2 Saudi Arabia Cardiovascular Implants Market by Application
9.4.5.3 U.A.E Cardiovascular Implants Market
9.4.5.3.1 U.A.E Cardiovascular Implants Market by Product
9.4.5.3.2 U.A.E Cardiovascular Implants Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Cardiovascular Implants Market Overview
9.5.2 South and Central America Cardiovascular Implants Market Forecasts and Analysis
9.5.3 South and Central America Cardiovascular Implants Market Forecasts and Analysis - By Product
9.5.4 South and Central America Cardiovascular Implants Market Forecasts and Analysis - By Application
9.5.5 South and Central America Cardiovascular Implants Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Cardiovascular Implants Market
9.5.5.1.1 Brazil Cardiovascular Implants Market by Product
9.5.5.1.2 Brazil Cardiovascular Implants Market by Application
9.5.5.2 Argentina Cardiovascular Implants Market
9.5.5.2.1 Argentina Cardiovascular Implants Market by Product
9.5.5.2.2 Argentina Cardiovascular Implants Market by Application
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. CARDIOVASCULAR IMPLANTS MARKET, KEY COMPANY PROFILES
11.1. VASCUTEK LTD (TERUMO CORPORATION)
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. EDWARDS LIFESCIENCES CORPORATION
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. COOK
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. MEDTRONIC
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. BOSTON SCIENTIFIC CORPORATION
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. ABBOTT
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. BIOTRONIK, INC.
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. SYNCARDIA SYSTEMS, LLC
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. LIVANOVA PLC
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. INTEGRA LIFESCIENCES
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Cardiovascular Implants Market - By Product
1.3.2 Cardiovascular Implants Market - By Application
1.3.3 Cardiovascular Implants Market - By Region
1.3.3.1 By Country
2. KEY TAKEWAYS
3. RESEARCH METHODOLOGY
4. CARDIOVASCULAR IMPLANTS MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PEST ANALYSIS
4.2.1 North America - Pest Analysis
4.2.2 Europe - Pest Analysis
4.2.3 Asia-Pacific - Pest Analysis
4.2.4 Middle East and Africa - Pest Analysis
4.2.5 South and Central America - Pest Analysis
4.3. EXPERT OPINIONS
5. CARDIOVASCULAR IMPLANTS MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS, RESTRAINTS & EXPECTED INFLUENCE OF COVID-19 PANDEMIC
6. CARDIOVASCULAR IMPLANTS MARKET - GLOBAL MARKET ANALYSIS
6.1. CARDIOVASCULAR IMPLANTS - GLOBAL MARKET OVERVIEW
6.2. CARDIOVASCULAR IMPLANTS - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE
7. CARDIOVASCULAR IMPLANTS MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. CORONARY STENT DEVICES
7.3.1. Overview
7.3.2. Coronary Stent Devices Market Forecast and Analysis
7.3.3. Bare Metal Stents Market
7.3.3.1. Overview
7.3.3.2. Bare Metal Stents Market Forecast and Analysis
7.3.4. Bioabsorbable Stents Market
7.3.4.1. Overview
7.3.4.2. Bioabsorbable Stents Market Forecast and Analysis
7.3.5. Drug Eluting Stents Market
7.3.5.1. Overview
7.3.5.2. Drug Eluting Stents Market Forecast and Analysis
7.4. PROSTHETIC HEART VALVES
7.4.1. Overview
7.4.2. Prosthetic Heart Valves Market Forecast and Analysis
7.4.3. Transcatheter Aortic Valve Implantation Market
7.4.3.1. Overview
7.4.3.2. Transcatheter Aortic Valve Implantation Market Forecast and Analysis
7.4.4. Mechanical Heart Valve Market
7.4.4.1. Overview
7.4.4.2. Mechanical Heart Valve Market Forecast and Analysis
7.4.5. Tissue Heart Valve Market
7.4.5.1. Overview
7.4.5.2. Tissue Heart Valve Market Forecast and Analysis
7.5. CARDIAC RHYTHM MANAGEMENT DEVICES
7.5.1. Overview
7.5.2. Cardiac Rhythm Management Devices Market Forecast and Analysis
7.5.3. Pacemaker Market
7.5.3.1. Overview
7.5.3.2. Pacemaker Market Forecast and Analysis
7.5.4. Cardiac Resynchronization Therapy Devices Market
7.5.4.1. Overview
7.5.4.2. Cardiac Resynchronization Therapy Devices Market Forecast and Analysis
7.5.5. Implantable Cardioverter Defibrillator Devices Market
7.5.5.1. Overview
7.5.5.2. Implantable Cardioverter Defibrillator Devices Market Forecast and Analysis
8. CARDIOVASCULAR IMPLANTS MARKET - REVENUE AND FORECASTS TO 2027 - APPLICATION
8.1. OVERVIEW
8.2. APPLICATION MARKET FORECASTS AND ANALYSIS
8.3. CONGESTIVE HEART FAILURE
8.3.1. Overview
8.3.2. Congestive Heart Failure Market Forecast and Analysis
8.4. ARRHYTHMIAS
8.4.1. Overview
8.4.2. Arrhythmias Market Forecast and Analysis
8.5. ACUTE MYOCARDIAL INFARCTION
8.5.1. Overview
8.5.2. Acute Myocardial Infarction Market Forecast and Analysis
8.6. MYOCARDIAL ISCHEMIA
8.6.1. Overview
8.6.2. Myocardial Ischemia Market Forecast and Analysis
8.7. OTHERS
8.7.1. Overview
8.7.2. Others Market Forecast and Analysis
9. CARDIOVASCULAR IMPLANTS MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Cardiovascular Implants Market Overview
9.1.2 North America Cardiovascular Implants Market Forecasts and Analysis
9.1.3 North America Cardiovascular Implants Market Forecasts and Analysis - By Product
9.1.4 North America Cardiovascular Implants Market Forecasts and Analysis - By Application
9.1.5 North America Cardiovascular Implants Market Forecasts and Analysis - By Countries
9.1.5.1 United States Cardiovascular Implants Market
9.1.5.1.1 United States Cardiovascular Implants Market by Product
9.1.5.1.2 United States Cardiovascular Implants Market by Application
9.1.5.2 Canada Cardiovascular Implants Market
9.1.5.2.1 Canada Cardiovascular Implants Market by Product
9.1.5.2.2 Canada Cardiovascular Implants Market by Application
9.1.5.3 Mexico Cardiovascular Implants Market
9.1.5.3.1 Mexico Cardiovascular Implants Market by Product
9.1.5.3.2 Mexico Cardiovascular Implants Market by Application
9.2. EUROPE
9.2.1 Europe Cardiovascular Implants Market Overview
9.2.2 Europe Cardiovascular Implants Market Forecasts and Analysis
9.2.3 Europe Cardiovascular Implants Market Forecasts and Analysis - By Product
9.2.4 Europe Cardiovascular Implants Market Forecasts and Analysis - By Application
9.2.5 Europe Cardiovascular Implants Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Cardiovascular Implants Market
9.2.5.1.1 Germany Cardiovascular Implants Market by Product
9.2.5.1.2 Germany Cardiovascular Implants Market by Application
9.2.5.2 France Cardiovascular Implants Market
9.2.5.2.1 France Cardiovascular Implants Market by Product
9.2.5.2.2 France Cardiovascular Implants Market by Application
9.2.5.3 Italy Cardiovascular Implants Market
9.2.5.3.1 Italy Cardiovascular Implants Market by Product
9.2.5.3.2 Italy Cardiovascular Implants Market by Application
9.2.5.4 Spain Cardiovascular Implants Market
9.2.5.4.1 Spain Cardiovascular Implants Market by Product
9.2.5.4.2 Spain Cardiovascular Implants Market by Application
9.2.5.5 United Kingdom Cardiovascular Implants Market
9.2.5.5.1 United Kingdom Cardiovascular Implants Market by Product
9.2.5.5.2 United Kingdom Cardiovascular Implants Market by Application
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Cardiovascular Implants Market Overview
9.3.2 Asia-Pacific Cardiovascular Implants Market Forecasts and Analysis
9.3.3 Asia-Pacific Cardiovascular Implants Market Forecasts and Analysis - By Product
9.3.4 Asia-Pacific Cardiovascular Implants Market Forecasts and Analysis - By Application
9.3.5 Asia-Pacific Cardiovascular Implants Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Cardiovascular Implants Market
9.3.5.1.1 Australia Cardiovascular Implants Market by Product
9.3.5.1.2 Australia Cardiovascular Implants Market by Application
9.3.5.2 China Cardiovascular Implants Market
9.3.5.2.1 China Cardiovascular Implants Market by Product
9.3.5.2.2 China Cardiovascular Implants Market by Application
9.3.5.3 India Cardiovascular Implants Market
9.3.5.3.1 India Cardiovascular Implants Market by Product
9.3.5.3.2 India Cardiovascular Implants Market by Application
9.3.5.4 Japan Cardiovascular Implants Market
9.3.5.4.1 Japan Cardiovascular Implants Market by Product
9.3.5.4.2 Japan Cardiovascular Implants Market by Application
9.3.5.5 South Korea Cardiovascular Implants Market
9.3.5.5.1 South Korea Cardiovascular Implants Market by Product
9.3.5.5.2 South Korea Cardiovascular Implants Market by Application
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Cardiovascular Implants Market Overview
9.4.2 Middle East and Africa Cardiovascular Implants Market Forecasts and Analysis
9.4.3 Middle East and Africa Cardiovascular Implants Market Forecasts and Analysis - By Product
9.4.4 Middle East and Africa Cardiovascular Implants Market Forecasts and Analysis - By Application
9.4.5 Middle East and Africa Cardiovascular Implants Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Cardiovascular Implants Market
9.4.5.1.1 South Africa Cardiovascular Implants Market by Product
9.4.5.1.2 South Africa Cardiovascular Implants Market by Application
9.4.5.2 Saudi Arabia Cardiovascular Implants Market
9.4.5.2.1 Saudi Arabia Cardiovascular Implants Market by Product
9.4.5.2.2 Saudi Arabia Cardiovascular Implants Market by Application
9.4.5.3 U.A.E Cardiovascular Implants Market
9.4.5.3.1 U.A.E Cardiovascular Implants Market by Product
9.4.5.3.2 U.A.E Cardiovascular Implants Market by Application
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Cardiovascular Implants Market Overview
9.5.2 South and Central America Cardiovascular Implants Market Forecasts and Analysis
9.5.3 South and Central America Cardiovascular Implants Market Forecasts and Analysis - By Product
9.5.4 South and Central America Cardiovascular Implants Market Forecasts and Analysis - By Application
9.5.5 South and Central America Cardiovascular Implants Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Cardiovascular Implants Market
9.5.5.1.1 Brazil Cardiovascular Implants Market by Product
9.5.5.1.2 Brazil Cardiovascular Implants Market by Application
9.5.5.2 Argentina Cardiovascular Implants Market
9.5.5.2.1 Argentina Cardiovascular Implants Market by Product
9.5.5.2.2 Argentina Cardiovascular Implants Market by Application
10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS
11. CARDIOVASCULAR IMPLANTS MARKET, KEY COMPANY PROFILES
11.1. VASCUTEK LTD (TERUMO CORPORATION)
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. EDWARDS LIFESCIENCES CORPORATION
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. COOK
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. MEDTRONIC
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. BOSTON SCIENTIFIC CORPORATION
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. ABBOTT
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. BIOTRONIK, INC.
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. SYNCARDIA SYSTEMS, LLC
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. LIVANOVA PLC
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10. INTEGRA LIFESCIENCES
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments
12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies
1. Vascutek Ltd (Terumo Corporation)
2. Edwards Lifesciences Corporation
3. Cook
4. Medtronic
5. Boston Scientific Corporation
6. Abbott
7. Biotronik, Inc.
8. Syncardia Systems, LLC
9. Livanova Plc
10. Integra Lifesciences
1. Vascutek Ltd (Terumo Corporation)
2. Edwards Lifesciences Corporation
3. Cook
4. Medtronic
5. Boston Scientific Corporation
6. Abbott
7. Biotronik, Inc.
8. Syncardia Systems, LLC
9. Livanova Plc
10. Integra Lifesciences